Skip to Main Content
Table 1 —

Characteristics of the study population

n 124 
Sex 53 male, 71 female 
Diagnosis 98 normal glucose tolerance, 26 impaired glucose tolerance 
Fasting glucose (mmol/l) 5.12 ± 0.58 
Fasting insulin (pmol/l) 36.9 (32.2–42.2) 
SG 0.0174 (0.0160–0.0188) 
SI (×10–5 min–1/[pmol/l]) 6.85 (5.84–8.03) 
AIRglucose (pmol/l) 179 (158–203) 
SI*AIRglucose 0.0115 (0.0093–0.0143) 
AIRtolbutamide (pmol/l) 346 (303–394) 
SI*AIRtolbutamide 0.0237 (0.0213–0.0263) 
n 124 
Sex 53 male, 71 female 
Diagnosis 98 normal glucose tolerance, 26 impaired glucose tolerance 
Fasting glucose (mmol/l) 5.12 ± 0.58 
Fasting insulin (pmol/l) 36.9 (32.2–42.2) 
SG 0.0174 (0.0160–0.0188) 
SI (×10–5 min–1/[pmol/l]) 6.85 (5.84–8.03) 
AIRglucose (pmol/l) 179 (158–203) 
SI*AIRglucose 0.0115 (0.0093–0.0143) 
AIRtolbutamide (pmol/l) 346 (303–394) 
SI*AIRtolbutamide 0.0237 (0.0213–0.0263) 

Characteristics of the full study population are shown. Skewed terms are means (95% CI); normal terms are means ± SD.

Close Modal

or Create an Account

Close Modal
Close Modal